Menu Close

Parallel Session: Cancer Related Cognitive Impairment in Patients with CNS Tumors: Are We Making Progress?



Dr Samantha Mayo
RBC Financial Group Chair in Oncology Nursing Research, Princess Margaret Cancer Centre, University Health Network, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto and Assistant Professor,  Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Canada
Session Chair

Dr Katherine Peters
Associate Professor, Neurology and Neurosurgery, Director of Supportive Care, Program Director, Neuro-Oncology Fellowship, Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine
Session Chair/Speaker

Dr Kim Edelstein
Neuropsychologist, Pencer Brain Tumor Center & Pediatric Aftercare Clinic, Scientist, Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, Canada

Dr Jeffrey Wefel
Chief, Section of Neuropsychology, Associate Professor, Departments of Neuro-Oncology and Radiation Oncology, The University of Texas MD Anderson Cancer Center,USA

Dr Benjamin Kye Jyn Tan
Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Assoc Prof Shelli Kesler
Associate Professor of Nursing and Diagnostic Medicine, University of Texas at Austin, USA

Dr Salome Adam
Scientific Research Associate, National Institute for Cancer Epidemiology and Registration (NICER), University of Zurich, Switzerland


  • Models of Supportive Care for Neuro-Oncology Patients and Families with Dr Kim Edelstein
  • Neuro Imaging Advances in Cancer Related Cognitive Impairment: Lessons Learned from Supportive Care with Dr Jeffrey Wefel
  • Oral Proffered Paper 1: The Phenotype & Value of Nerve Conduction Studies in Measuring Chemotherapy-Induced Peripheral Neuropathy: A Secondary Pooled Analysis of Five Studies with Dr Benjamin Kye Jyn Tan
  • Oral Proffered Paper 2: Neurophenotypes of the Psychoneurological Symptom Cluster in Breast Cancer Survivors with Assoc Prof Shelli Kesler
  • Oral Proffered Paper 3: Identifying Classes Of The Psycho-Neurological Symptom Cluster in Long-Term Prostate Cancer Survivors with Dr Salome Adam
  • Oral Proferred Paper 4: Cognitive Outcomes of Phase 1 Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients with Dr Katherine Peters

Disclaimer: The views and opinions of presenters do not necessarily reflect those of MASCC or ISOO.